期刊文献+

FGF23在慢性肾脏病中的研究进展 被引量:2

Research progress in FGF23 in chronic kidney disease
下载PDF
导出
摘要 慢性肾脏病(chronic kidney disease,CKD)已经成为全球性的健康问题。CKD患者几乎都存在着不同程度的钙磷代谢紊乱、贫血等问题,对患者生活质量和预后造成严重影响。成纤维生长因子(fibroblast growth factor 23,FGF23)是近年来的研究热点,其在骨矿物质代谢、贫血等方面发挥重要调节作用。FGF23可通过多种途径调节血磷,血清FGF23浓度与贫血存在相关性。 Chronic kidney disease (CKD) has become a global health problem. CKD patients almost all have different levels of calcium and phosphorus metabolism disorders, anemia and other issues, which have a serious impact on patients' quality of life and prognosis. Fibroblast growth factor 23 (FGF23) is a research hotspot in recent years, which plays an important regulatory role in bone mineral metabolism and anemia. FGF23 can regulate blood phosphorus in a variety of ways, and serum FGF23 concentration is associated with anemia.
作者 蔡明 王兴智 CAI Ming;WANG Xingzhi(Department of Nephrology, First Affiliated Hospital of Harbin Medical University, Harbin 150000, China)
出处 《临床与病理杂志》 2019年第6期1327-1330,共4页 Journal of Clinical and Pathological Research
基金 黑龙江省教育厅海外学人科研资助项目(1253HQ006)~~
关键词 慢性肾脏病 成纤维生长因子 促红细胞生成素 贫血 chronic kidney disease fibroblast growth factor 23 erythropoietin anemia
  • 相关文献

同被引文献24

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部